Safety of aripiprazole: high serum levels in a CYP2D6 mutated patient.
Oosterhuis
Marieke
M
Van De Kraats
Gerben
G
Tenback
Diederik
D
D014150:Antipsychotic Agents / Q000097:blood* / Q000378:metabolism / Q000627:therapeutic use; D000068180:Aripiprazole; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D010879:Piperazines / Q000097:blood* / Q000378:metabolism / Q000627:therapeutic use; D015363:Quinolones / Q000097:blood* / Q000378:metabolism / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy / Q000235:genetics
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole; D019389:Cytochrome P-450 CYP2D6